Evidence map›Paper›PMID 41480615›Full record

ArticleWorld journal of diabetes2025

Impact of diabetes mellitus on mortality and atrial fibrillation in hypertrophic cardiomyopathy: A systematic review and meta-analysis.

Nanush Damarlapally, Roopeessh Vempati, Kesha Mayank Doshi, Manavjot Singh, Kesar Prajapati, Dhruvi Modi, Pooja Singh, Rupak Desai

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of diabetes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nanush DamarlapallyDepartment of Health Sciences, Houston Community College-Coleman Campus, Houston, TX 77030, United States.
Roopeessh VempatiDepartment of Internal Medicine, Trinity Health Oakland Hospital, Pontiac, MI 48341, United States.
Kesha Mayank DoshiDepartment of Medicine, Byramjee Jeejeebhoy Medical College, Ahmedabad 380016, India.
Manavjot SinghDepartment of Medicine, Dayanand Medical College, Ludhiana 141001, Punjab, India.
Kesar PrajapatiDepartment of Internal Medicine, Metropolitan Hospital Center, New York City Health and Hospitals Corporation, New York, NY 10029, United States.
Dhruvi ModiDepartment of Internal Medicine, Gujarat Adani Institute of Medical Sciences, Bhuj 370001, Gujarat, India.
Pooja SinghDepartment of Internal Medicine, Multicare Tacoma General Hospital, Tacoma, WA 98405, United States.
Rupak DesaiIndependent Researcher, Atlanta, GA 30079, United States. drrupakdesai@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetes mellitus (DM) is a significant risk factor for cardiovascular diseases and can worsen the risk of cardiovascular events among patients with hypertrophic cardiomyopathy (HCM). However, strong evidence is needed to show the impact of DM on all-cause mortality (ACM) and atrial fibrillation (AF), which we explored in this systematic review and meta-analysis.

aimTo determine the impact of DM on ACM and AF in patients with HCM.

methodsPubMed, Google Scholar, and EMBASE databases were searched for studies showing the effect of DM on ACM and AF in HCM. A binary random effects model with a 95% confidence interval (CI) was used to pool odds ratios (ORs) for ACM and AF outcomes. Study quality was assessed using the Joanna Briggs Institute's critical appraisal tool and leave-one-out sensitivity analysis.

resultsFourteen studies (

conclusionDM significantly increased the risk of ACM and AF, highlighting the importance of tighter glycemic control and cardiovascular risk factor modification among patients with HCM.

Indexed as

All-cause mortalityArrhythmiaAtrial fibrillationCardiovascular diseaseDiabetes mellitusHeart failureHypertrophic cardiomyopathyHypertrophic obstructive cardiomyopathy

Identifiers

PMID41480615
PMCPMC12754091

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.